Turacoz Group Showcases AI-Powered Systematic Reviews at World EPA 2025

Turacoz Group has showcased its advancements in AI-powered living systematic reviews at the World Evidence, Pricing and Access (EPA) Congress, Europe 2025, announced in a press release. The event, held in Utrecht, Netherlands, brought together global healthcare leaders to discuss AI-driven innovations in evidence synthesis and market access strategies.

Dr. Namrata Singh, Founder and CEO of Turacoz Group, delivered a presentation titled "Revolutionizing Evidence Synthesis – The Role of Artificial Intelligence in Living Systematic Reviews (LSRs)." The presentation explored how machine learning and automation are transforming evidence synthesis, enabling real-time literature updates, and improving healthcare decision-making.

Turacoz also presented a scientific poster on AI-driven methodologies, demonstrating its commitment to advancing evidence synthesis. The company emphasized the critical role of AI in modern evidence-based medicine, highlighting how AI-powered solutions enhance the accuracy, timeliness, and accessibility of medical insights. These innovations support informed decision-making across the healthcare industry, improving patient care and driving scientific progress.